Psygen was founded by Danny Motyka, Peter van der Heyden.

Who are Psygen's investors?

Psygen's investors include Iter Investments, Noetic, Eight Capital.

Psygen

3 known investors

Find your way into Psygen

Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use. The company serves researchers, physicians, and healthcare systems working within regulated compassionate-use and special access programs.

Biotech Deep Tech Healthtech Medical Devices Mental Health

Founders & leadership

Danny MotykainCo-Founder & CEO

Peter van der HeydeninCo-Founder & Director

Investors · 3

Iter InvestmentsSouth Florida

NoeticToronto

Eight Capitalreported · 2 sourcesCaguas

In the news

Psychedelic Bulletin #122: Lusaris Raises $60m to Develop 5-MeO-DMT; First Take-Home Psilocybin Trial in N. America; COMPASS Phase 2b Published in NEJM - Psychedelic Alphapsychedelicalpha.com · Nov 2022

This Calgary-based company wants to become a psychedelic unicorn | CBC Newscbc.ca · Dec 2021

Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction of 1290442 B.C. Ltd. by Psygen Industries Ltd. and Brokered Financing Led by Eight Capital and Canaccord - BioSpacebiospace.com · Mar 2021

List of Top Psychedelics Startups That Raised the Most Funding in 2020 - Business Insiderbusinessinsider.com · Mar 2021

Frequently asked questions

What does Psygen do?: Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use. The company serves researchers, physicians, and healthcare systems working within regulated compassionate-use and special access programs.
Who founded Psygen?: Psygen was founded by Danny Motyka, Peter van der Heyden.
Who are Psygen's investors?: Psygen's investors include Iter Investments, Noetic, Eight Capital.